Last reviewed · How we verify

NCT04860193

Audio Vestibular Functions in COVID 19 Patients in Sohag Governate

Completed Last updated 6 December 2024
What this trial tests

trial in COVID19 in 150 participants. Completed in 18 March 2023.

Timeline
14 August 2021
Primary endpoint
10 December 2021
18 March 2023

Quick facts

Lead sponsorSohag University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment150
Start date14 August 2021
Primary completion10 December 2021
Estimated completion18 March 2023
Sites1 location across Egypt

Conditions studied

Sponsor

Sohag University

Who can join

Adults 20 to 50, any sex, with COVID19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There is evidence that up to 30% of COVID-19 patients was reported with neurological manifestations such as impaired consciousness, headache, and dizziness have been reported in COVID-19 patients in addition, olfactory and taste alterations are common symptoms in patients affected by COVID-19.This study will be conducted to evaluate the effect of the novel coronavirus on audio-vestibular functions in confirmed COVID19 patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for COVID19

Currently open trials in the same condition.

Other Sohag University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04860193.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing